ガイドライン

(旧版)エビデンスとコンセンサスを統合した潰瘍性大腸炎の診療ガイドライン ―難治性炎症性腸管障害に関する調査研究班 プロジェクト研究グループ

書誌情報
 
推奨ステートメントと解説


3.活動期の遠位大腸炎における緩解導入治療

引用文献

1) Kornbluth A, Sachar DB. Ulcerative colitis practice guideline in adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gasteroenterol 2004;99:1371-1385.
2) Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited. A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993;118:540-549.
3) Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334:841-8.
4) Katz S. Update in medical therapy of ulcerative colitis. J Clin Gastroenterol 2002;34:397-407.
5) Stevens AC. Sulfasalazine and 5-aminosalicylates in the treatement of inflammatory bowel disease. UpToDate 2005, version 13.2.
6) Gisbert JP, Gomollon F, MateJ, Pajares JM. Role of 5-aminosalicylic acid in treatment of inflammatory bowel disease. Dig Dis Sci 2002;47:471-488.
7) MacDermott RP, Bonis PAL. Management of ulcerative proctitis and left-sided colitis. UpToDate 2005, version 13.2.
8) Sutherland LR, Martin F, Greer S, et al.5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-8.
9) Marshall JK, Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther. 1995;9:293-300.
10) Campieri M, Gionchetti P, Beluzzi A, et al. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut. 1991;32:929-31.
11) Friedman LS, Richter JM, Kirkham SE, DeMonaco HJ, May RJ. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Am J Gastroenterol. 1986;81:412-8.
12) Mulder CJ, Tytgat GN, Wiltink EH, Houthoff HJ. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. Scand J Gastroenterol. 1988;23:1005-8.
13) Porro GB, Ardizzone S, Petrillo M, et al. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. Am J Gastroenterol. 1995;90:736-9.
14) Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53(Suppl V):v1-v16.
15) Kam L, Cohen H, Dooley C, Rubin P, Orchard J. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Am J Gastroenterol. 1996;91:1338-42.
16) Cobden I, al-Mardini H, Zaitoun A, Record CO. Is topical therapy necessary in acute distal colitis? Double-blind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis. Aliment Pharmacol Ther. 1991;5:513-22.
17) Safdi M, DeMicco M, Sninsky C, Banks P, Wruble L, Deren J, Koval G, Nichols T, Targan S, Fleishman C, Wiita B.  A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol. 1997;92:1867-71.

 

書誌情報